Clinical Trials Browser

Phase NA × Esophageal Squamous Cell Carcinoma × sintilimab × Clear all

NCT07067450 2025-07-16

Adjuvant Immunotherapy for Esophageal Squamous Cell Carcinoma

Phase NA Not yet recruiting

Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT04813406 2021-03-24

Study of Anlotinib Plus Sintilimab in the Treatment of Advanced Esophageal Squamous Cell Carcinoma

Phase NA Unknown

Gastrointestinal

Esophageal Squamous Cell Carcinoma